Key Clinical MessageC1 esterase inhibitor (Berinert®) is generally used to treat severe attack of hereditary angioedema. We describe here the case of a patient who presented with a severe angioedema induced by angiotensin-converting enzyme inhibitors (ACEIs) endangering her life. It could be successfully treated with that medicine.

The aim of this report is to describe and evaluate the reliability of a minimally invasive pocket (MIP) technique for the implantation of the Neurelec Digisonic SP cochlear implant. The skin incision is made at the back of the auricular concha. The device fixation and stability relies on natural pericranial pressure by the creation of a narrow subperiosteal pocket. There's no need for any additional fixation. In our institution, 19 patients underwent cochlear implantation using the MIP technique. Age ranged from 18 months to 73 years. The patients were reviewed for surgical implantation technique, intra- and postoperative complications, and postoperative hearing results. All patients were successfully implanted with a secure fixation. The MIP technique is particularly interesting to apply in young children.

Endoscopic endonasal surgery has become a standard procedure for functional treatment of benign pathologies. Materials and improved surgeon skills have allowed the number of indications for this approach to increase. We describe some of the main pathologies, including malignancies, that can be treated endoscopically, focussing on the orbital and skull base pathologies. The orbital indications discussed here are dacryocystorhinostomy, orbital decompression, and optic nerve decompression. Advantages of endoscopic surgery for aggressive benign tumours such as inverted papilloma and juvenile nasopharyngeal angiofibroma are described. The skull base pathologies detailed are ethmoid adenocarcinoma and esthesioneuroblastoma for the anterior skull base surgery and endoscopic transsphenoidal approach to the sella for pituitary tumour surgery. Evidence of the safety and efficacy of endoscopic surgery is increasing but there is a lack of randomised long-term studies.

In our study, 71 normal-hearing ears from adults and 39 from neonates (n = 110) were tested by the advanced echo test technique devised and described by Kemp (ILO 88). Almost all ears (97% and 95%) showed emissions. This material is convenient for clinical routine in adults and for neonatal screening.

Introduction The BAHA (bone-anchored hearing aid) Attract is a magnetic transcutaneous bone conduction device anchored into the temporal bone. The standard surgical technique for BAHA Attract is a multi-tools time-consuming process, which requires a large cutaneous incision. The objective of this study is to describe and test the feasibility of a minimally invasive pocket (MIP) technique for Magnet Bone Implant Hearing Aid (MBIHA) with a modified magnet of BAHA Attract without fixation and without any tissue reduction. We use a 3-cm vertical skin incision and a subperiosteal pocket. Method A study of 10 patients with conductive or mixed hearing loss who benefited from a MBIHA using the MIP technique is presented. The pure tone average (PTA) (dB) for air-conduction thresholds and the speech recognition threshold (SRT) (dB) in speech audiometry in quiet are calculated. The Entific Medical Systems (EMS) questionnaire and the postoperative clinical outcomes are realized. Results We found a significant improvement of 33.8 dB on average for the PTA and 44.8 dB for the SRT with MBIHA at 3 months, compared with unaided situation. No implant was removed or displaced after 2 years of follow-up. The skin condition remains intact in all the cases. Conclusion The minimally subperiosteal pocket surgical technique MIP without fixation and with tissue preservation for the MBIHA is safe, rapid and effective for patients with conductive or mixed hearing loss. It opens new perspectives of development and modify conventional concept in magnetic coupling of bone-conducted device.